The Acta Group, Bergeson & Campbell, P.C.'s consulting affiliate, is participating in a webinar on chemical regulation in China with its joint venture partner Acta-PLS China on May 31, 2012. Leslie S. MacDougall, Andy Burgess, and Dr. Ya-Juin Chou, Novartis Pharma AG, will address the key elements of chemical control legislation in China, including the new chemical substance notification order, Ministry of Environmental Protection's Order Number 7, and the new decree regarding safe management of hazardous chemicals, State Council Decree 591. Speakers will explain the legislation, provide practical experience and advice, and give tips for industry compliance. A question and answer session will follow the webinar presentations. Registration is available online.
About Bergeson & Campbell, P.C. -- Located in Washington, D.C., B&C is a law firm focusing on conventional, biobased, and nanoscale industrial, agricultural, and specialty chemical product regulation and approval matters, including Toxic Substances Control Act (TSCA) matters, Federal Insecticide, Fungicide and Rodenticide Act (FIFRA)/Food Quality Protection Act (FQPA) matters, U.S. Food and Drug Administration (FDA) medical device and product approval, registration and data compensation arbitrations, chemical product litigation, and associated business counseling and litigation issues. B&C's clients are involved in many businesses, including conventional, biobased, and nanoscale basic, specialty, and agricultural and antimicrobial chemicals; biotechnology, nanotechnology, and emerging transformative technologies; medical devices and diagnostic products; paints and coatings; plastic products; and chemical manufacturing, formulation, distribution, and consumer product sectors. Additional information is available at www.lawbc.com.
About The Acta Group -- Acta is a consulting affiliate of B&C, established to control the inefficiencies encountered by clients seeking approvals to market agricultural and industrial chemicals, products of biotechnology and nanotechnology, and FDA-regulated products. Acta's practice is global, with staff in North America, Europe, and Asia. Additional information is available at www.actagroup.com.